Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,536,800 | 2,021,900 | 2,606,200 | 1,125,100 | 1,352,400 |
| Marketable Securities | 1,717,800 | 1,180,500 | 749,500 | 1,184,200 | 829,200 |
| Receivables | 5,262,400 | 4,089,000 | 3,374,100 | 2,876,700 | 2,655,900 |
| Inventories | 3,021,500 | 2,846,900 | 2,623,900 | 2,145,100 | 2,148,800 |
| Other current assets | 0 | 1,120,900 | 874,800 | 881,900 | 740,300 |
| TOTAL | $13,597,900 | $11,259,200 | $10,228,500 | $8,213,000 | $7,726,600 |
| Non-Current Assets | |||||
| PPE Net | 11,482,100 | 9,676,700 | 7,843,800 | 6,609,400 | 5,926,700 |
| Investments And Advances | 4,947,800 | 4,761,500 | 3,607,700 | 2,533,400 | 2,499,400 |
| Other Non-Current Assets | 10,127,100 | 9,937,500 | 10,173,400 | 8,456,100 | 8,140,400 |
| TOTAL | $26,557,000 | $24,375,700 | $21,624,900 | $17,598,900 | $16,566,500 |
| Total Assets | $40,154,900 | $35,634,900 | $31,853,400 | $25,811,900 | $24,293,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 902,500 | 606,100 |
| Accounts payable and accrued liabilities | 4,605,800 | 4,158,700 | 3,682,100 | 3,268,900 | 2,937,800 |
| Other current liabilities | N/A | 677,000 | 637,400 | 537,600 | 482,700 |
| TOTAL | $9,954,100 | $8,758,800 | $6,068,800 | $5,568,600 | $4,829,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,600,700 | 3,143,900 | 3,220,800 | 1,346,500 | 1,155,900 |
| Other Non-Current Liabilities | 5,021,000 | 3,460,500 | 3,705,000 | 1,184,400 | 2,310,200 |
| TOTAL | $15,368,400 | $13,634,500 | $12,982,800 | $7,629,800 | $7,493,400 |
| Total Liabilities | $25,322,500 | $22,393,300 | $19,051,600 | $13,198,400 | $12,322,600 |
| Shareholders' Equity | |||||
| Common Shares | 29,700 | 29,700 | 29,700 | 5,254,000 | 4,967,500 |
| Retained earnings | 27,363,900 | 23,447,900 | 20,186,700 | 17,319,400 | 14,817,700 |
| Other shareholders' equity | 31,000 | 8,500 | -21,100 | 100 | 300 |
| TOTAL | $14,832,400 | $13,241,600 | $12,801,800 | $12,613,500 | $11,970,500 |
| Total Liabilities And Equity | $40,154,900 | $35,634,900 | $31,853,400 | $25,811,900 | $24,293,100 |